期刊文献+

再生障碍性贫血免疫损伤机制及相关淋巴细胞的研究 被引量:2

原文传递
导出
摘要 再生障碍性贫血的发病机制还未完全明确,其研究进展不断有所报道。随着对其发病机制研究的不断深入和对临床经验的不断总结,除外T淋巴细胞免疫功能紊乱,B细胞介导的体液免疫紊乱和再生障碍性贫血的关系也逐渐受到重视,特别是和再障相关的体液因子。现在就这方面作一综述,希望能为实验研究及临床治疗提供更多的思路。
机构地区 浙江中医药大学
出处 《黑龙江中医药》 2016年第1期68-70,共3页 Heilongjiang Journal of Traditional Chinese Medicine
基金 浙江省科技厅社会发展项目(NO:2014C33273)
  • 相关文献

参考文献24

  • 1邝璞,刘霆.免疫功能紊乱相关的获得性单纯性红细胞再生障碍性贫血[J].华西医学,2010,25(11):2111-2113. 被引量:2
  • 2付蓉,邵宗鸿.CD5+B淋巴细胞与自身免疫性疾病[J].国外医学(输血及血液学分册),2001,24(6):486-489. 被引量:13
  • 3滕广帅,付蓉,刘惠,王红蕾,王一浩,阮二宝,瞿文,梁勇,王国锦,王晓明,刘鸿,吴玉红,宋嘉,王化泉,邢莉民,关晶,王珺,李丽娟,邵宗鸿.免疫相关性全血细胞减少症患者树突状细胞亚群、数量及其临床意义[J].中国实验血液学杂志,2012,20(3):722-726. 被引量:11
  • 4Chen J, Ellison FM, EckhausMA, etal. MinorAntigen h60-mediatedaplastic anemia is ameliorated byimmunosuppression and the infusion ofregulatoryT cells[J]. J Immunol, 2007, 178(7): 4159-4168.
  • 5Hansen PB, Lauritzen AM. Aplasticanemia successfully tr eated with rituximab[J]. Am J Hematol. 2005,80(4):292- 294.
  • 6Gomez-Almaguer D, Jaime-PerezJC, GuillermoJ, et al. Antibodies in the Treatment of Aplastic Anemia[J].Arch Immunol Ther Exp, 2012,60(2):99-106.
  • 7Teramura M, Kobayashi S, Iwabe K, et al. Mechanism of action antithymocyte globulin in the treatment of aplastic anaemia:in vitro evidence for the presence of immunosuppressive mechanism. Br J Haemato1,1997,96(1):80-84.
  • 8Toyoshima I,Yu H, Steuer ER, et al. Kinectin, a major kinesin-binding protein on ER[J].J Cell Bio1,1992,118(5):1121-1131.
  • 9Leung E, Print CG, Parry DA, et al. Cloning of novel Kinectin splice variants with alternative C-termini: structure, distribution and evolution of mouse kinectin[J].Immunol Cell Bio1,1996,74(5):421-433.
  • 10Hirano N, Butler MO, Von Bergwelt-BaildonMS, et al. Autoantibodies frequently detected in patients with aplastic anemia [J].Blood. 2003,102(13):4567-4575.

二级参考文献38

  • 1邵宗鸿,付蓉.免疫相关性血细胞减少症——一种新认知的疾病(上)[J].中国医刊,2005,40(1):5-8. 被引量:56
  • 2邵宗鸿,付蓉.免疫相关性血细胞减少症——一种新认知的疾病(下)[J].中国医刊,2005,40(2):6-9. 被引量:58
  • 3邢莉民,邵宗鸿,付蓉,刘鸿,施均,白洁,涂梅峰,王化泉,崔振珠,贾海蓉,孙娟,杨崇礼.自身免疫性血细胞减少症患者骨髓CD_5^+B细胞数量变化及其临床意义[J].中国实用内科杂志,2005,25(11):994-996. 被引量:8
  • 4Handgretinger R, Geiselhart A, Moris A, et al. Pure red-cell aplasia associated with clonal expansion of granular lyrnphocytes expressing killer-cell inhibitory receptors[J]. N Engl J Med, 1999, 340(4):278- 284.
  • 5Bigouret V, Hoffmann T, Arlettaz L, et al. Monoclonal T-ceil expansions in asymptomatic individuals and in patients with large granular leukemia consist of cytotoxic effector T cells expressing the activating CD94 : NKG2C/E and NKD2D killer cell receptors [J]. Blood, 2003, 101(8),3198-3204.
  • 6Sivakumaran M,Bhavnani M, Stewart A, et al. Is pure red cell aplasia (PRCA) a clonal disorder? [J]. Clin Lab Haematol, 1993, 15(1) :1-5.
  • 7Nadeau L,Meyerson H,Warren G, et al. A sustained response to low dose interferon-alpha in a case of refractory pure red cell aplasia[J]. Eur J Haematol, 2004, 73(4):300-303.
  • 8Sawada K, Hirokawa M,Fujishima N, et al. Long-term outcome of patients with acquired primary idiopathic pure red cell aplasia receiving cyclosporine A. A nationwide cohort study in Japan for the PRCA Collaborative Study Group [J ]. Haematologica, 2007, 92(8) : 1021-1028.
  • 9Charles RJ, Sabo KM, Kidd PG, et al. The pathophysiology of pure red cell aplasia:implications for therapy[J]. Blood, 1996, 87(11) :4831-4838.
  • 10Lacy MQ,Kurtin PJ,Tefferi A. Pure red cell aplasia:association with large granular lymphocyte leukemia and the prognostic value of cytogenetic abnormalities [J]. Blood, 1996, 87 (7) : 3000-3006.

共引文献23

同被引文献13

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部